Skip to main content
Top
Published in: Journal of Clinical Monitoring and Computing 4/2016

01-08-2016 | Original Research

The prevalence of long QT interval in post-operative intensive care unit patients

Authors: Julius Cuong Pham, Michael C. Banks, David L. Narotsky, Todd Dorman, Bradford D. Winters

Published in: Journal of Clinical Monitoring and Computing | Issue 4/2016

Login to get access

Abstract

The severity of patient illnesses and medication complexity in post-operative critically ill patients increase the risk for a prolonged QT interval. We determined the prevalence of prolonged QTc in surgical intensive care unit (SICU) patients. We performed a prospective cross-sectional study over a 15-month period at a major academic center. SICU pre-admission and admission EKGs, patient demographics, and laboratory values were analyzed. QTc was evaluated as both a continuous and dichotomous outcome (prolonged QTc > 440 ms). 281 patients were included in the study: 92 % (n = 257) post-operative and 8 % (n = 24) non-operative. On pre-admission EKGs, 32 % of the post-operative group and 42 % of the non-operative group had prolonged QTc (p = 0.25); on post-admission EKGs, 67 % of the post-operative group but only 33 % of the non-operative group had prolonged QTc (p < 0.01). The average change in QTc in the post-operative group was +30.7 ms, as compared to +2 ms in the non-operative group (p < 0.01). On multivariable adjustment for long QTc as a dichotomous outcome, pre-admission prolonged QTc (OR 3.93, CI 1.93–8.00) and having had an operative procedure (OR 4.04, CI 1.67–9.83) were associated with developing prolonged QTc. For QTc as a continuous outcome, intra-operative beta-blocker use was associated with a statistically-significant decrease in QTc duration. None of the patients developed a lethal arrhythmia in the ICU. Prolonged QTc is common among post-operative SICU patients (67 %), however lethal arrhythmias are uncommon. The operative experience increases the risk for long QTc.
Literature
2.
go back to reference Bayes de Luna A, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J. 1989;117:151–9.CrossRefPubMed Bayes de Luna A, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J. 1989;117:151–9.CrossRefPubMed
3.
go back to reference Priori SG, Aliot E, Blomstrom-Lundqvist C, et al. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J. 2001;22:1374–450.CrossRefPubMed Priori SG, Aliot E, Blomstrom-Lundqvist C, et al. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J. 2001;22:1374–450.CrossRefPubMed
4.
go back to reference Schwartz PJ, Priori SG, Cerrone M, et al. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation. 2004;109:1826–33.CrossRefPubMed Schwartz PJ, Priori SG, Cerrone M, et al. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation. 2004;109:1826–33.CrossRefPubMed
5.
go back to reference Groh WJ, Silka MJ, Oliver RP, et al. Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. Am J Cardiol. 1996;78:703–6.CrossRefPubMed Groh WJ, Silka MJ, Oliver RP, et al. Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. Am J Cardiol. 1996;78:703–6.CrossRefPubMed
7.
go back to reference Bazett HC. An analysis of the time-relations of electrocardiograms. Heart. 1920;7:353. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart. 1920;7:353.
8.
go back to reference Al-Khatib SM, LaPointe NM, Kramer JM, et al. What clinicians should know about the QT interval. JAMA. 2003;289:2120.CrossRefPubMed Al-Khatib SM, LaPointe NM, Kramer JM, et al. What clinicians should know about the QT interval. JAMA. 2003;289:2120.CrossRefPubMed
9.
go back to reference Drici MD, Clément N. Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome. Drug Saf. 2001;24:575.CrossRefPubMed Drici MD, Clément N. Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome. Drug Saf. 2001;24:575.CrossRefPubMed
10.
go back to reference Goldberg R, Bengston J, Chen Z, et al. Duration of the QT interval and total and cardiovascular mortality in healthy persons (the Framingham heart study experience). Am Heart J. 1991;67:55–8. Goldberg R, Bengston J, Chen Z, et al. Duration of the QT interval and total and cardiovascular mortality in healthy persons (the Framingham heart study experience). Am Heart J. 1991;67:55–8.
11.
go back to reference Cubeddu LX. QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs. Am J Ther. 2003;10:452–7.CrossRefPubMed Cubeddu LX. QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs. Am J Ther. 2003;10:452–7.CrossRefPubMed
12.
go back to reference Drew BJ, Ackerman MJ, Funk M, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2010;121:1047.CrossRefPubMedPubMedCentral Drew BJ, Ackerman MJ, Funk M, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2010;121:1047.CrossRefPubMedPubMedCentral
13.
go back to reference Wisely NA, Shipton EA. Long QT syndrome and anesthesia. Eur J Anesthesiol. 2002;19:853–9.CrossRef Wisely NA, Shipton EA. Long QT syndrome and anesthesia. Eur J Anesthesiol. 2002;19:853–9.CrossRef
14.
go back to reference Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm. 2011;8:1308.CrossRefPubMed Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm. 2011;8:1308.CrossRefPubMed
15.
go back to reference Smithburger PL, Seybert AL, Armahizer MJ, et al. QT prolongation in the intensive care unit: commonly used medications and the impact of drug–drug interactions. Expert Opin Drug Saf. 2010;9:699–712.CrossRefPubMed Smithburger PL, Seybert AL, Armahizer MJ, et al. QT prolongation in the intensive care unit: commonly used medications and the impact of drug–drug interactions. Expert Opin Drug Saf. 2010;9:699–712.CrossRefPubMed
16.
go back to reference Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002;30:119–41.CrossRefPubMed Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002;30:119–41.CrossRefPubMed
17.
go back to reference Ng TMH, Olsen KM, McCartan MA, et al. Drug-induced QTc-interval prolongation in the intensive care unit: incidence and predictors. J Pharm Pract. 2010;23:19–24.CrossRefPubMed Ng TMH, Olsen KM, McCartan MA, et al. Drug-induced QTc-interval prolongation in the intensive care unit: incidence and predictors. J Pharm Pract. 2010;23:19–24.CrossRefPubMed
18.
go back to reference Kopp BJ, Erstad BL, Allen ME, et al. Medication errors and adverse drug events in an intensive care unit: direct observation approach for detection. Crit Care Med. 2006;34:415–25.CrossRefPubMed Kopp BJ, Erstad BL, Allen ME, et al. Medication errors and adverse drug events in an intensive care unit: direct observation approach for detection. Crit Care Med. 2006;34:415–25.CrossRefPubMed
19.
go back to reference Krishnan V, Murray P. Pharmacologic issues in the critically ill. Clin Chest Med. 2003;24:671–88.CrossRefPubMed Krishnan V, Murray P. Pharmacologic issues in the critically ill. Clin Chest Med. 2003;24:671–88.CrossRefPubMed
20.
go back to reference Volberg WA, Koci BJ, Su W, et al. Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics. J Pharmacol Exp Ther. 2002;302:320.CrossRefPubMed Volberg WA, Koci BJ, Su W, et al. Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics. J Pharmacol Exp Ther. 2002;302:320.CrossRefPubMed
21.
go back to reference Kane-Gill SL, Weber RJ. Principles and practices of medication safety in the ICU. Crit Care Clin. 2006;22:273–90.CrossRefPubMed Kane-Gill SL, Weber RJ. Principles and practices of medication safety in the ICU. Crit Care Clin. 2006;22:273–90.CrossRefPubMed
22.
go back to reference Goldstein DS. The electrocardiogram in stroke: relationship to pathophysiological type and comparison with prior tracings. Stroke. 1979;10:253.CrossRefPubMed Goldstein DS. The electrocardiogram in stroke: relationship to pathophysiological type and comparison with prior tracings. Stroke. 1979;10:253.CrossRefPubMed
23.
go back to reference Isner JM, Sours HE, Paris AL, et al. Sudden, unexpected death in avid dieters using the liquid-protein-modified-fast diet: observations in 17 patients and the role of the prolonged QT interval. Circulation. 1979;60:1401–12.CrossRefPubMed Isner JM, Sours HE, Paris AL, et al. Sudden, unexpected death in avid dieters using the liquid-protein-modified-fast diet: observations in 17 patients and the role of the prolonged QT interval. Circulation. 1979;60:1401–12.CrossRefPubMed
25.
go back to reference Tzivoni D, Banai S, Schuger C, et al. Treatment of torsade de pointes with magnesium sulfate. Circulation. 1988;77:392.CrossRefPubMed Tzivoni D, Banai S, Schuger C, et al. Treatment of torsade de pointes with magnesium sulfate. Circulation. 1988;77:392.CrossRefPubMed
26.
go back to reference Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol. 2006;48:e247–346.CrossRefPubMed Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol. 2006;48:e247–346.CrossRefPubMed
27.
go back to reference Kaltman JR, Ro PS, Stephens P, et al. Effects of beta-adrenergic antagonists on the QT measurement from exercise stress tests. Pediatr Cardiol. 2003;24(6):553–8.CrossRefPubMed Kaltman JR, Ro PS, Stephens P, et al. Effects of beta-adrenergic antagonists on the QT measurement from exercise stress tests. Pediatr Cardiol. 2003;24(6):553–8.CrossRefPubMed
28.
go back to reference Lock G, Fialho GL, Lima DC, et al. Electrocardiographic changes after neostigmine–atropine mixture. J Anesth Clin Res. 2012;3:188.CrossRef Lock G, Fialho GL, Lima DC, et al. Electrocardiographic changes after neostigmine–atropine mixture. J Anesth Clin Res. 2012;3:188.CrossRef
29.
go back to reference Golzari H, Dawson NV, Speroff T, et al. Prolonged QTc intervals on admission electrocardiograms: prevalence and correspondence with admission electrolyte abnormalities. Conn Med. 2007;71:389–97.PubMed Golzari H, Dawson NV, Speroff T, et al. Prolonged QTc intervals on admission electrocardiograms: prevalence and correspondence with admission electrolyte abnormalities. Conn Med. 2007;71:389–97.PubMed
30.
go back to reference Seftchick MW, Adler PH, Hsieh M, et al. The prevalence and factors associated with QTc prolongation among emergency department patients. Ann Emerg Med. 2009;54:763–8.CrossRefPubMed Seftchick MW, Adler PH, Hsieh M, et al. The prevalence and factors associated with QTc prolongation among emergency department patients. Ann Emerg Med. 2009;54:763–8.CrossRefPubMed
31.
go back to reference Tisdale JE, Wroblewski HA, Overholser BR, et al. Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the US. Drug Saf. 2012;35:459–70.CrossRefPubMed Tisdale JE, Wroblewski HA, Overholser BR, et al. Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the US. Drug Saf. 2012;35:459–70.CrossRefPubMed
32.
go back to reference Nagele P, Pal S, Brown F, et al. Postoperative QT interval prolongation in patients undergoing noncardiac surgery under general anesthesia. Anesthesiology. 2012;117:321–8.CrossRefPubMedPubMedCentral Nagele P, Pal S, Brown F, et al. Postoperative QT interval prolongation in patients undergoing noncardiac surgery under general anesthesia. Anesthesiology. 2012;117:321–8.CrossRefPubMedPubMedCentral
33.
go back to reference Waxler B, Margeta B, Tureanu L, et al. Duration of the surgery and age are risk factors for QTc interval prolongation under general anesthesia with volatile anesthetics. J Anesth Clin Res. 2012;3:254.CrossRef Waxler B, Margeta B, Tureanu L, et al. Duration of the surgery and age are risk factors for QTc interval prolongation under general anesthesia with volatile anesthetics. J Anesth Clin Res. 2012;3:254.CrossRef
34.
go back to reference Goldenberg I, Horr S, Moss AJ, et al. Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. J Am Coll Card. 2010;57(1):51–9.CrossRef Goldenberg I, Horr S, Moss AJ, et al. Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. J Am Coll Card. 2010;57(1):51–9.CrossRef
35.
go back to reference Pickham D, Helfenbein E, Shinn JA, et al. High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality: results of the QT in Practice (QTIP) Study. Crit Care Med. 2012;40:394–9.CrossRefPubMed Pickham D, Helfenbein E, Shinn JA, et al. High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality: results of the QT in Practice (QTIP) Study. Crit Care Med. 2012;40:394–9.CrossRefPubMed
36.
go back to reference Makkar RR, Fromm BS, Steinman RT, et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA. 1993;270(21):2590–7.CrossRefPubMed Makkar RR, Fromm BS, Steinman RT, et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA. 1993;270(21):2590–7.CrossRefPubMed
37.
go back to reference Hnatkova K, Gang Y, Batchvarov VN, et al. Precision of QT interval measurement by advanced electrocardiographic equipment. Pacing Clin Electrophysiol. 2006;29:1277–84.CrossRefPubMed Hnatkova K, Gang Y, Batchvarov VN, et al. Precision of QT interval measurement by advanced electrocardiographic equipment. Pacing Clin Electrophysiol. 2006;29:1277–84.CrossRefPubMed
38.
go back to reference Marquette™ 12SL™ ECG analysis program: physician’s guide, revision E. Waukesha, WI: GE Healthcare; 2008, p. 6–73. Marquette™ 12SL™ ECG analysis program: physician’s guide, revision E. Waukesha, WI: GE Healthcare; 2008, p. 6–73.
39.
go back to reference Miller MD, Porter CB, Ackerman MJ. Diagnostic accuracy of screening electrocardiograms in long QT syndrome I. Pediatrics. 2001;108(1):8–12.CrossRefPubMed Miller MD, Porter CB, Ackerman MJ. Diagnostic accuracy of screening electrocardiograms in long QT syndrome I. Pediatrics. 2001;108(1):8–12.CrossRefPubMed
40.
go back to reference Savelieva I, Yi G, Guo X, Hnatkova K, Malik M. Agreement and reproducibility of automatic versus manual measurement of QT interval and QT dispersion. Am J Cardiol. 1998;81(4):471–7.CrossRefPubMed Savelieva I, Yi G, Guo X, Hnatkova K, Malik M. Agreement and reproducibility of automatic versus manual measurement of QT interval and QT dispersion. Am J Cardiol. 1998;81(4):471–7.CrossRefPubMed
Metadata
Title
The prevalence of long QT interval in post-operative intensive care unit patients
Authors
Julius Cuong Pham
Michael C. Banks
David L. Narotsky
Todd Dorman
Bradford D. Winters
Publication date
01-08-2016
Publisher
Springer Netherlands
Published in
Journal of Clinical Monitoring and Computing / Issue 4/2016
Print ISSN: 1387-1307
Electronic ISSN: 1573-2614
DOI
https://doi.org/10.1007/s10877-015-9736-1

Other articles of this Issue 4/2016

Journal of Clinical Monitoring and Computing 4/2016 Go to the issue